Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quviviq 25mg tablets
0401040A0BBAAAA
|
Quviviq | Daridorexant | Central Nervous System | 121 |
|
Reminyl XL 24mg capsules
0411000F0BBAHAG
|
Reminyl | Galantamine | Central Nervous System | 119 |
|
Doxepin 10mg capsules
0403010L0AAAAAA
|
Doxepin | Doxepin | Central Nervous System | 118 |
|
Panitaz 5micrograms/hour transdermal patches
0407020B0BLAAAH
|
Panitaz | Buprenorphine | Central Nervous System | 118 |
|
Xeplion 100mg/1ml prolonged-release inj pf syringes
0402020ABBBACAC
|
Xeplion | Paliperidone | Central Nervous System | 118 |
|
Atrolak XL 50mg tablets
0402010ABBGAAAV
|
Atrolak XL | Quetiapine | Central Nervous System | 117 |
|
Morphine 120mg modified-release capsules
0407020Q0AADVDV
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 117 |
|
Prozac 20mg capsules
0403030E0BBAAAA
|
Prozac | Fluoxetine hydrochloride | Central Nervous System | 117 |
|
Cynril 200microgram loz with integral oromucosal applicator
0407020A0BWAAAI
|
Cynril | Fentanyl | Central Nervous System | 116 |
|
Methylphenidate 2mg/ml oral solution sugar free
0404000M0AABCBC
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 115 |
|
Carlosafine 35micrograms/hour transdermal patches
0407020B0BTAAAE
|
Carlosafine | Buprenorphine | Central Nervous System | 113 |
|
Ebixa 10mg tablets
0411000G0BBAAAA
|
Ebixa | Memantine hydrochloride | Central Nervous System | 113 |
|
Melatonin 3mg/5ml oral suspension
0401010ADAACBCB
|
Melatonin | Melatonin | Central Nervous System | 113 |
|
Chloral hydrate 1g/5ml oral solution BP
0401010B0AABWBW
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 112 |
|
Fentanyl 400microgram sublingual tablets sugar free
0407020A0AAAZAZ
|
Fentanyl | Fentanyl | Central Nervous System | 111 |
|
Axalid 100mg capsules
0408010AEBFADAD
|
Axalid | Pregabalin | Central Nervous System | 110 |
|
Maxolon 10mg tablets
0406000P0BBAAAE
|
Maxolon | Metoclopramide hydrochloride | Central Nervous System | 109 |
|
Enodama 50mg tablets
0408010U0BCAAAX
|
Enodama | Primidone | Central Nervous System | 108 |
|
Gabapentin 400mg/5ml oral suspension
0408010G0AABHBH
|
Gabapentin | Gabapentin | Central Nervous System | 108 |
|
Melatonin 4mg/5ml oral suspension
0401010ADAADCDC
|
Melatonin | Melatonin | Central Nervous System | 108 |
|
Strattera 18mg capsules
0404000S0BBACAC
|
Strattera | Atomoxetine hydrochloride | Central Nervous System | 108 |
|
Zamadol 50mg capsules
040702040BDAAAA
|
Zamadol | Tramadol hydrochloride | Central Nervous System | 108 |
|
Zyprexa 15mg Velotabs
040201060BBAGAK
|
Zyprexa | Olanzapine | Central Nervous System | 108 |
|
Inovelon 400mg tablets
0408010AFBBACAC
|
Inovelon | Rufinamide | Central Nervous System | 107 |
|
Melatonin 2.5mg capsules
0401010ADAAAHAH
|
Melatonin | Melatonin | Central Nervous System | 106 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.